Latest Insider Transactions at Orthofix Medical Inc. (OFIX)
This section provides a real-time view of insider transactions for Orthofix Medical Inc. (OFIX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Orthofix Medical Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Orthofix Medical Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2025
|
Geoffrey C Gillespie CAO |
SELL
Open market or private sale
|
Direct |
296
-0.69%
|
$4,736
$16.6 P/Share
|
|
Mar 18
2025
|
Lucas Vitale CP&BOO |
SELL
Open market or private sale
|
Direct |
4,287
-3.07%
|
$68,592
$16.6 P/Share
|
|
Mar 11
2025
|
Vickie L Capps |
BUY
Grant, award, or other acquisition
|
Direct |
3,093
+50.0%
|
-
|
|
Mar 05
2025
|
Massimo Calafiore President & CEO |
BUY
Open market or private purchase
|
Direct |
9,914
+4.27%
|
$168,538
$17.43 P/Share
|
|
Mar 03
2025
|
Geoffrey C Gillespie CAO |
BUY
Grant, award, or other acquisition
|
Direct |
3,681
+7.92%
|
-
|
|
Mar 03
2025
|
Max Reinhardt President, Global Spine |
BUY
Grant, award, or other acquisition
|
Direct |
14,723
+33.58%
|
-
|
|
Mar 03
2025
|
Massimo Calafiore President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
88,339
+29.37%
|
-
|
|
Mar 03
2025
|
Julie Andrews CFO |
BUY
Grant, award, or other acquisition
|
Direct |
34,600
+35.48%
|
-
|
|
Mar 03
2025
|
Jorge Andres Cedron CLO |
BUY
Grant, award, or other acquisition
|
Direct |
17,668
+27.61%
|
-
|
|
Mar 03
2025
|
Patrick Fisher President, Global Orthopedics |
BUY
Grant, award, or other acquisition
|
Direct |
14,723
+32.89%
|
-
|
|
Mar 03
2025
|
Lucas Vitale CP&BOO |
BUY
Grant, award, or other acquisition
|
Direct |
14,723
+9.54%
|
-
|
|
Feb 04
2025
|
Geoffrey C Gillespie CAO |
SELL
Open market or private sale
|
Direct |
187
-0.48%
|
$3,366
$18.08 P/Share
|
|
Feb 03
2025
|
Geoffrey C Gillespie CAO |
SELL
Open market or private sale
|
Direct |
767
-1.91%
|
$13,039
$17.79 P/Share
|
|
Jan 16
2025
|
Julie Andrews CFO |
SELL
Open market or private sale
|
Direct |
4,655
-14.12%
|
$79,135
$17.89 P/Share
|
|
Jan 13
2025
|
Geoffrey C Gillespie CAO |
SELL
Open market or private sale
|
Direct |
227
-0.56%
|
$3,859
$17.14 P/Share
|
|
Jan 13
2025
|
Massimo Calafiore President & CEO |
SELL
Open market or private sale
|
Direct |
9,203
-6.9%
|
$156,451
$17.14 P/Share
|
|
Jan 10
2025
|
Geoffrey C Gillespie CAO |
SELL
Open market or private sale
|
Direct |
248
-0.61%
|
$3,968
$16.83 P/Share
|
|
Jan 10
2025
|
Massimo Calafiore President & CEO |
SELL
Open market or private sale
|
Direct |
10,078
-7.03%
|
$161,248
$16.83 P/Share
|
|
Jan 08
2025
|
Geoffrey C Gillespie CAO |
SELL
Open market or private sale
|
Direct |
238
-0.58%
|
$3,808
$16.97 P/Share
|
|
Jan 07
2025
|
Geoffrey C Gillespie CAO |
SELL
Open market or private sale
|
Direct |
238
-0.58%
|
$4,046
$17.14 P/Share
|
|
Dec 17
2024
|
Geoffrey C Gillespie CAO |
SELL
Open market or private sale
|
Direct |
26
-0.06%
|
$442
$17.84 P/Share
|
|
Aug 15
2024
|
Patrick Fisher President, Global Orthopedics |
BUY
Grant, award, or other acquisition
|
Direct |
15,319
+50.0%
|
$245,104
$16.32 P/Share
|
|
Jun 18
2024
|
John B Henneman Iii |
BUY
Grant, award, or other acquisition
|
Direct |
15,152
+19.16%
|
$181,824
$12.87 P/Share
|
|
Jun 18
2024
|
Shweta Maniar |
BUY
Grant, award, or other acquisition
|
Direct |
15,152
+30.07%
|
$181,824
$12.87 P/Share
|
|
Jun 18
2024
|
Michael E Paolucci |
BUY
Grant, award, or other acquisition
|
Direct |
15,152
+18.5%
|
$181,824
$12.87 P/Share
|
|
Jun 18
2024
|
Jason Hannon |
BUY
Grant, award, or other acquisition
|
Direct |
15,152
+23.49%
|
$181,824
$12.87 P/Share
|
|
Jun 18
2024
|
Charles R. Kummeth |
BUY
Grant, award, or other acquisition
|
Direct |
15,152
+28.24%
|
$181,824
$12.87 P/Share
|
|
Jun 18
2024
|
Wayne Burris |
BUY
Grant, award, or other acquisition
|
Direct |
15,152
+32.34%
|
$181,824
$12.87 P/Share
|
|
Jun 18
2024
|
Michael Finegan |
BUY
Grant, award, or other acquisition
|
Direct |
21,368
+41.83%
|
$256,416
$12.87 P/Share
|
|
Jun 18
2024
|
Alan Lee Bazaar |
BUY
Grant, award, or other acquisition
|
Direct |
15,152
+38.61%
|
$181,824
$12.87 P/Share
|
|
Jun 10
2024
|
Max Reinhardt President, Global Spine |
BUY
Grant, award, or other acquisition
|
Direct |
14,401
+50.0%
|
$187,213
$13.02 P/Share
|
|
Jun 08
2024
|
Kimberley A. Elting President, Global Orthopedics |
SELL
Payment of exercise price or tax liability
|
Direct |
4,267
-1.84%
|
$55,471
$13.42 P/Share
|
|
Apr 15
2024
|
Jorge Andres Cedron CLO |
BUY
Grant, award, or other acquisition
|
Direct |
28,648
+50.0%
|
$372,424
$13.09 P/Share
|
|
Apr 11
2024
|
Kimberley A. Elting President, Global Orthopedics |
SELL
Payment of exercise price or tax liability
|
Direct |
2,938
-1.25%
|
$38,194
$13.95 P/Share
|
|
Apr 08
2024
|
Catherine M Burzik |
SELL
Payment of exercise price or tax liability
|
Direct |
47,486
-29.63%
|
$664,804
$14.23 P/Share
|
|
Apr 01
2024
|
Kimberley A. Elting President, Global Orthopedics |
SELL
Payment of exercise price or tax liability
|
Direct |
2,031
-0.86%
|
$28,434
$14.06 P/Share
|
|
Apr 01
2024
|
Geoffrey C Gillespie CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
70
-0.17%
|
$980
$14.06 P/Share
|
|
Mar 15
2024
|
Geoffrey C Gillespie CAO |
BUY
Grant, award, or other acquisition
|
Direct |
3,639
+8.18%
|
$47,307
$13.74 P/Share
|
|
Feb 01
2024
|
Kimberley A. Elting President, Global Orthopedics |
SELL
Payment of exercise price or tax liability
|
Direct |
2,015
-0.84%
|
$28,210
$14.27 P/Share
|
|
Jan 31
2024
|
Michael Finegan |
BUY
Grant, award, or other acquisition
|
Direct |
8,350
+50.0%
|
$108,550
$13.89 P/Share
|
|
Jan 31
2024
|
Alan Lee Bazaar |
BUY
Grant, award, or other acquisition
|
Direct |
8,936
+50.0%
|
$116,168
$13.89 P/Share
|
|
Jan 31
2024
|
Charles R. Kummeth |
BUY
Grant, award, or other acquisition
|
Direct |
8,350
+26.34%
|
$108,550
$13.89 P/Share
|
|
Jan 15
2024
|
Julie Andrews CFO |
BUY
Grant, award, or other acquisition
|
Direct |
32,967
+50.0%
|
$428,571
$13.65 P/Share
|
|
Jan 08
2024
|
Massimo Calafiore President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
141,084
+50.0%
|
$1,834,092
$13.29 P/Share
|
|
Jan 08
2024
|
Kevin J. Kenny President of Global Spine |
SELL
Payment of exercise price or tax liability
|
Direct |
1,511
-1.03%
|
$19,643
$13.29 P/Share
|
|
Jan 08
2024
|
Kevin J. Kenny President of Global Spine |
BUY
Exercise of conversion of derivative security
|
Direct |
5,959
+3.89%
|
-
|
|
Jan 08
2024
|
Geoffrey C Gillespie CAO |
BUY
Grant, award, or other acquisition
|
Direct |
4,703
+11.17%
|
$61,139
$13.29 P/Share
|
|
Jan 08
2024
|
Kimberley A. Elting President, Global Orthopedics |
SELL
Grant, award, or other acquisition
|
Direct |
18,811
-7.3%
|
$244,543
$13.29 P/Share
|
|
Jan 05
2024
|
Kevin J. Kenny President of Global Spine |
SELL
Payment of exercise price or tax liability
|
Direct |
2,955
-2.05%
|
$35,460
$12.67 P/Share
|
|
Jan 05
2024
|
Geoffrey C Gillespie CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
459
-1.39%
|
$5,508
$12.67 P/Share
|